These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31283782)

  • 1. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
    Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ
    PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.
    Harter MR; Liu CD; Shen CL; Gonzalez-Hurtado E; Zhang ZM; Xu M; Martinez E; Peng CW; Song J
    PLoS Pathog; 2016 Feb; 12(2):e1005414. PubMed ID: 26845565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif.
    Ansieau S; Leutz A
    J Biol Chem; 2002 Feb; 277(7):4906-10. PubMed ID: 11733528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.
    Rowe M; Raithatha S; Shannon-Lowe C
    J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
    Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
    PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
    Fuentes-Pananá EM; Ling PD
    J Virol; 1998 Jan; 72(1):693-700. PubMed ID: 9420275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
    Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
    Gordadze AV; Onunwor CW; Peng R; Poston D; Kremmer E; Ling PD
    J Virol; 2004 Apr; 78(8):3919-29. PubMed ID: 15047808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
    Su C; Lu F; Soldan SS; Lamontagne RJ; Tang HY; Napoletani G; Farrell PJ; Tempera I; Kossenkov AV; Lieberman PM
    PLoS Pathog; 2021 Aug; 17(8):e1009834. PubMed ID: 34352044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
    Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.
    McCann EM; Kelly GL; Rickinson AB; Bell AI
    J Gen Virol; 2001 Dec; 82(Pt 12):3067-3079. PubMed ID: 11714985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.
    Mühe J; Wang F
    PLoS Pathog; 2017 Dec; 13(12):e1006772. PubMed ID: 29261800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
    Beer S; Wange LE; Zhang X; Kuklik-Roos C; Enard W; Hammerschmidt W; Scialdone A; Kempkes B
    Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2200512119. PubMed ID: 35857872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBNA2 and Its Coactivator EBNA-LP.
    Kempkes B; Ling PD
    Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
    Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.
    Cancian L; Bosshard R; Lucchesi W; Karstegl CE; Farrell PJ
    PLoS Pathog; 2011 Jul; 7(7):e1002164. PubMed ID: 21857817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
    Tierney RJ; Kao KY; Nagra JK; Rickinson AB
    J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.